REGENERON PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Regeneron Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
  • Regeneron Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $990M, a 1.78% increase year-over-year.
  • Regeneron Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $3.99B, a 1.39% decline year-over-year.
  • Regeneron Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was $3.99B, a 1.39% decline from 2023.
  • Regeneron Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $4.05B, a 14.6% decline from 2022.
  • Regeneron Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $4.74B, a 47% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.99B -$56.4M -1.39% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-05
2023 $4.05B -$692M -14.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-05
2022 $4.74B -$4.21B -47% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-05
2021 $8.95B +$5.37B +150% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-05
2020 $3.58B +$1.37B +61.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-06
2019 $2.21B -$325M -12.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-07
2018 $2.53B +$455M +21.9% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-08
2017 $2.08B +$749M +56.3% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-07
2016 $1.33B +$78.8M +6.29% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-07
2015 $1.25B +$428M +51.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-08
2014 $824M +$80.9M +10.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-09
2013 $743M +$285M +62.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-11
2012 $458M +$663M Jan 1, 2012 Dec 31, 2012 10-K 2015-02-12
2011 -$205M -$108M -110% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-13
2010 -$97.5M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.